Arctoris
Arctoris accelerates drug discovery by generating high‑quality, reproducible experimental data to improve decision-making and speed programs toward the clinic. It operates as a drug discovery services company/Partnership Research Organization that combines its proprietary Ulysses automation platform with laboratory scientists to run biochemical, cellular, protein‑science and preclinical assays. The platform integrates robotics, wet‑lab automation, data science and AI with methods such as high‑content imaging, flow cytometry, sequencing (RNA‑Seq/Tempo‑Seq), qRT‑PCR/dPCR, biophysical screening, fragment‑based discovery and computational design. Arctoris partners with biotech and pharmaceutical companies on target validation, hit finding, hit‑to‑lead and lead optimization, offering an agile, client‑focused alternative to traditional CROs. Its approach targets faster, data‑driven progression of programs from target identification through preclinical development.
Arctoris
Arctoris accelerates drug discovery by generating high‑quality, reproducible experimental data to improve decision-making and speed programs toward the clinic. It operates as a drug discovery services company/Partnership Research Organization that combines its proprietary Ulysses automation platform with laboratory scientists to run biochemical, cellular, protein‑science and preclinical assays. The platform integrates robotics, wet‑lab automation, data science and AI with methods such as high‑content imaging, flow cytometry, sequencing (RNA‑Seq/Tempo‑Seq), qRT‑PCR/dPCR, biophysical screening, fragment‑based discovery and computational design. Arctoris partners with biotech and pharmaceutical companies on target validation, hit finding, hit‑to‑lead and lead optimization, offering an agile, client‑focused alternative to traditional CROs. Its approach targets faster, data‑driven progression of programs from target identification through preclinical development.